Science advances · 2023
Identifying high-grade serous ovarian carcinoma-specific extracellular vesicles by polyketone-coated nanowires.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Yokoi Akira, Ukai Mayu, Yasui Takao, Inokuma Yasuhide, Hyeon-Deuk Kim, Matsuzaki Juntaro, Yoshida Kosuke, Kitagawa Masami, Chattrairat Kunanon, Iida Mikiko, Shimada Taisuke, Manabe Yumehiro, Chang I-Ya, Asano-Inami Eri, Koya Yoshihiro, Nawa Akihiro, Nakamura Kae, Kiyono Tohru, Kato Tomoyasu, Hirakawa Akihiko, Yoshioka Yusuke, Ochiya Takahiro, Hasegawa Takeshi, Baba Yoshinobu, Yamamoto Yusuke, Kajiyama Hiroaki
Аннотация
Cancer cell-derived extracellular vesicles (EVs) have unique protein profiles, making them promising targets as disease biomarkers. High-grade serous ovarian carcinoma (HGSOC) is the deadly subtype of epithelial ovarian cancer, and we aimed to identify HGSOC-specific membrane proteins. Small EVs (sEVs) and medium/large EVs (m/lEVs) from cell lines or patient serum and ascites were analyzed by LC-MS/MS, revealing that both EV subtypes had unique proteomic characteristics. Multivalidation steps identified FRα, Claudin-3, and TACSTD2 as HGSOC-specific sEV proteins, but m/lEV-associated candidates were not identified. In addition, for using a simple-to-use microfluidic device for EV isolation, polyketone-coated nanowires (pNWs) were developed, which efficiently purify sEVs from biofluids. Multiplexed array assays of sEVs isolated by pNW showed specific detectability in cancer patients and predicted clinical status. In summary, the HGSOC-specific marker detection by pNW are a promising platform as clinical biomarkers, and these insights provide detailed proteomic aspects of diverse EVs in HGSOC patients.